WebJeffrey Robert Ajer Age : 59 Public asset : 6,629,164 USD Linked companies : BioMarin Pharmaceutical Inc. - Nektar Therapeutics Summary Jeffrey Robert Ajer is Chief Commercial Officer & Executive VP of BioMarin Pharmaceutical, Inc. He is also on the board of Nektar Therapeutics. Web8 gen 2024 · Treatment centers are ready to go, and our market research indicates that there are approximately 40 patients queued up for pre-treatment screening," said Jeff Ajer, Executive Vice President and Chief Commercial Officer of BioMarin. "We are pleased that these outcomes-based agreements will enable access for individuals with severe …
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2024 Earnings …
Web27 ott 2024 · On the call from BioMarin's management team today are JJ Bienaime, Chairman and Chief Executive Officer; Jeff Ajer, Executive Vice President, Chief Commercial Officer; Hank Fuchs, President... WebAs Executive Vice President, Chief Commercial Officer at BIOMARIN PHARMACEUTICAL INC, Jeff Ajer made $4,985,409 in total compensation. Of this total $610,000 was received as a salary, $567,300 was received as a bonus, $841,896 was received in stock options, $2,941,280 was awarded as stock and $24,933 came from other types of compensation. … hanging orchids in trees
BioMarin Pharmaceutical Inc. (BMRN) CEO J.J. Bienaime on Q1 …
Web24 ago 2024 · BioMarin hosted a conference call to discuss Roctavian’s EU approval, launch plans, and pricing agreements: On the call: Jean-Jacques Bienaimé (CEO), Henry J. Fuchs (President, Worldwide R&D), Jeff Ajer (CCO), Brian R. Mueller (CFO) Details on the expected label: Contraindicated for active infections and known liver issues WebExcelente oportunidade para aprender sobre pesquisa clínica e networking! Web17 nov 2024 · Jeff Ajer is currently Executive Vice President and Chief Commercial Officer at Biomarin Pharmaceutical and Independent Director at Nektar Therapeutics. Jeff Ajer … hanging orchids images